Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Viking Therapeutics, Inc.
(Exact name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| | | | | | | |
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit (2) | Maximum Aggregate Offering Price(2) | Fee Rate | Amount of Registration Fee |
Equity | Common Stock, par value $0.00001 per share | 457(h) | 2,738,694(3) | $3.46 | $9,475,881.24 | 0.0000927 | $878.41 |
Equity | Common Stock, par value $0.00001 per share | 457(h) | 782,484(4) | $3.46 | $2,707,394.64 | 0.0000927 | $250.98 |
Total Offering Amounts | $12,183,275.88 | — | $1,129.39 |
Total Fee Offsets | — | — | — |
Net Fee Due | — | — | $1,129.39 |
| |
(1) | Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s Common Stock (“Common Stock”) that become issuable under the Viking Therapeutics, Inc. 2014 Equity Incentive Plan (the “2014 Plan”) and the Viking Therapeutics, Inc. 2014 Employee Stock Purchase Plan, as amended (the “2014 ESPP”), by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Common Stock. |
(2) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. The proposed maximum offering price per share and the proposed maximum aggregate offering price with respect to the shares are calculated based on $3.46 per share, the average of the high and low prices of the Common Stock, as reported on the Nasdaq Capital Market on February 3, 2022, a date within five business days prior to the filing of this Registration Statement. |
(3) | Represents shares of Common Stock that were automatically added to the shares reserved for issuance under the 2014 Plan on January 1, 2022. The 2014 Plan provides that an additional number of shares will automatically be added annually to the shares authorized for issuance under the 2014 Plan on January 1st of each year commencing on January 1, 2016 and ending on (and including) January 1, 2024. The number of shares added each year will be equal to 3.5% of the total number of shares of Common Stock outstanding on December 31st of the preceding calendar year. |
(4) | Represents shares of Common Stock that were automatically added to the shares reserved for issuance under the 2014 ESPP on January 1, 2022. The 2014 ESPP provides that an additional number of shares will automatically be added annually to the shares authorized for issuance under the 2014 ESPP on January 1st of each year commencing on January 1, 2016 and ending on (and including) January 1, 2024. The number of shares added each year will be equal to 1% of the total number of shares of Common Stock outstanding on December 31st of the preceding calendar year. |
LEGAL_US_W # 111115892.1
